Contract

Requirement For Producer Cell Line For GMP Viral Vector Packaging

  • NHS Blood and Transplant

F03: Contract award notice

Notice identifier: 2022/S 000-010087

Procurement identifier (OCID): ocds-h6vhtk-032e03

Published 14 April 2022, 3:34pm



Section one: Contracting authority

one.1) Name and addresses

NHS Blood and Transplant

500 North Bristol Park

Bristol

BS34 7QH

Contact

Marnie Watkins

Email

marnie.watkins@nhsbt.nhs.uk

Telephone

+44 1179217241

Country

United Kingdom

NUTS code

UKK11 - Bristol, City of

National registration number

NHS Blood and Transplant

Internet address(es)

Main address

https://www.nhsbt.nhs.uk/

Buyer's address

https://www.nhsbt.nhs.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Requirement For Producer Cell Line For GMP Viral Vector Packaging

two.1.2) Main CPV code

  • 33141000 - Disposable non-chemical medical consumables and haematological consumables

two.1.3) Type of contract

Supplies

two.1.4) Short description

NHSBT’s Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £111,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

NHSBT’s Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2020/S 108-263380


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

7 April 2022

five.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from other EU Member States: 0

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

LIFE TECHNOLOGIES LIMITED

3 Fountain Drive, Inchinnan Business Park,

Paisley

PA4 9RF

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

SC083107

Internet address

www.thermofisher.com

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £100,000

Lowest offer: £111,000 / Highest offer: £111,000 taken into consideration


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

NHS Blood and Transplant

500 North Bristol Park

Bristol

BS34 7QH

Country

United Kingdom

Internet address

https://www.nhsbt.nhs.uk/